Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 Relative risk for myocardial infarction in OSA patients heterozygous for β2-adrenergic receptor polymorphisms.

From: Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of β2-adrenergic receptor polymorphisms

 

n (%)

Relative risk for myocardial infarction: odds ratio (95% confidence interval)

P

All

429

  

Heterozygote: Cys-47Arg

195 (45.2)

0.32 (0.13–0.82)

0.012

Heterozygote: Arg16Gly

197 (45.9)

0.39 (0.16–0.94)

0.031

Heterozygote: Gln27Glu

202 (47.1)

0.37 (0.15–0.89)

0.023

Haplotype Cys-47Arg/Arg16Gly/Gln27Glu

113 (26.3)

0.21 (0.05–0.90)

0.023

  1. Significant P factors are shown in bold.
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us